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ABSTRACT: The clinical significance of asymptomatic bronchial hyperrespon­
siveness (BHR) is not well-known. The aim of this study was to explore, in a cross- 
sectional analysis, the characteristics of adolescent subjects with asymptomatic 
BHR, as compared to nonhyperresponsive subjects and those with symptomatic 
BHR. The subjects were selected by date of birth from the register of general prac­
titioners. The hypothesis that both asymptomatic and symptomatic BHR are rela­
ted to early childhood lower respiratory tract infections was also tested, in a historical 
cohort analysis.
Respiratory morbidity was studied in early childhood and BHR in adolescence 
and young adulthood, in a population of 551 subjects aged 10-23 yrs. Morbidity 
had been recorded prospectively since birth in the general practice. Data on chro­
nic respiratory symptoms, smoking behaviour, airways obstruction, BHR and 
allergy were collected during this investigation.
BHR was present in 42% of the subjects, of which 70% were asymptomatic. 
The occurrence of symptomatic BHR was related to acute bronchitis in early child­
hood, allergy, airways obstruction and recent asthma, acute bronchitis and hay 
fever; whereas, asymptomatic BHR was not. Characteristics of subjects with 
asymptomatic BHR did not differ significantly from those without BHR, with res­
pect to these factors.
We conclude that asymptomatic bronchial hyperresponsiveness in adolescence 
and young adulthood is not related to lower respiratory infections in early child­
hood. Furthermore, subjects with asymptomatic bronchial hyperresponsiveness 
have similar characteristics to those without bronchial hyperresponsiveness, but 
differ strongly from subjects with symptomatic hyperresponsiveness. Asymptomatic 
bronchia] hyperresponsiveness may not be the link between early childhood lower 
respiratory morbidity and asthma in later life, nor a risk factor for later asthma. 
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Bronchial hyperresponsiveness (BHR) is characteris­
tic* though not specific, for asthma; it is also present in 
chronic airflow limitation, rhinitis and after upper or 
lower respiratory tract infections (LRTI) [1, 2]. In popu­
lation studies, up to 58% of hyperresponsive subjects 
did not report respiratory symptoms [3-5]. The clinical 
significance of asymptomatic BHR is, therefore, still 
unclear. Spontaneous remissions have been reported in 
children [6, 7] but poor perception of dyspnoea has also 
been suggested as an explanation [8], Other studies 
have demonstrated that asymptomatic BHR precedes 
the development of asthma [9, 10] suggesting that it is 
a risk factor for development of asthma at a later stage. 
If this is true, it might be expected that, with respect 
to asthma characteristics, subjects with asymptomatic 
BHR would be comparable to those with symptomatic 
BHR (asthma), and would differ from subjects without 
BHR.
Z h o n g  et al. [10] demonstrated an increased tenden­
cy to develop asthma in asymptomatic hyperresponsive 
adolescents with a history of acute respiratory illness in 
early childhood. This would support a theoretical model,
which implies that LRTI in early childhood are a risk 
factor for the development of asthma [11, 12]. Acquired 
changes in the bronchial (sub)mucosa could manifest 
themselves as BHR, which may initially persist without 
symptoms, but may become symptomatic in later life, 
possibly because of environmental factors. If BHR is 
the essential link in the evolution from LRTI in early 
childhood to asthma, then this BHR should be related 
to the incidence of LRTI in early childhood, both for 
symptomatic and for asymptomatic BHR.
The aim of this study was to answer the following 
questions:
1. What is the prevalence of BHR, both asymptomatic 
and symptomatic forms, in a sample of subjects select­
ed from registers of general practitioners on the criter­
ion of age 10-23 yrs (hereafter, referred to as adolescents 
and young adults)?
2. Are both forms of BHR in adolescence and young 
adulthood related to LRTI in early childhood?
3. Do subjects with asymptomatic and those with 
symptomatic BHR have similar personal characteristics 
and clinical characteristics related to asthma?
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Methods and materials
A cohort of children from general practice records 
was followed from birth to the age of 10—23 yrs, Morbid­
ity data was prospectively recorded from birth onwards. 
The respiratory status at the age of 10-23 yrs was stud­
ied by use of a questionnaire, spirometry and a hista­
mine challenge test.
Study population
The 581 participating subjects (40% of the original 
birth cohort) were recruited from the registers of the prac­
tice population of the Continuous Morbidity Registra­
tion (CMR), Department of General Practice, University 
of Nijmegen, The Netherlands. Subjects were recruited 
from these records, only on the basis of their date of 
birth. Under the structure of the Dutch health care sys­
tem, professional medical care can only be obtained 
through primary care. Listing with a general practitioner 
is compulsory under every insurance scheme, and each 
general practice has a fixed, identifiable and unselec­
ted list of patients [13, 14].
The registration started in 1967, and the study was 
confined to all subjects born before 1979, to guarantee 
a follow-up of 10 yrs from birth. Of the 1,441 children 
born during that period, 492 had left the area at the time 
of the study, and 23 had died of a non-respiratory cause. 
The remaining 926 subjects were invited to take part in 
the study (fig. 1). A written and oral explanation was 
given to the subjects, and to their parents if they were
Fig. 1, -  Diagram of the study group, of the original birth cohort 
in the open population from which it was recruited, and of the sub­
divisions into the hyperresponsive or nonhyperresponsive categories, 
with and without complaints.
aged <16 yrs. They were asked to complete a respira­
tory questionnaire and to undergo spirometry and a his­
tamine challenge test. Of this group, 581 subjects (63%) 
participated in this study. The data of 30 subjects were 
excluded from analyses and are referred to as nonper- 
formers: three subjects were not able to perform repro­
ducible forced expiratory manoeuvres, seven could not 
finish the challenge test due to cough, although forced 
expiratory volume in one second (FEVi) was not sig­
nificantly decreased; and 20 subjects did not complete 
the questionnaire satisfactorily. None of the subjects had 
an initial FEVi <50% of predicted, or <1 L, so that all 
551 participants underwent the histamine challenge test.
The CMR (the characteristics have been described 
elsewhere) [12, 15] provided the following informa­
tion: 1) the early childhood respiratory morbidity during 
the first 5 yrs of life, and the recent respiratory mor­
bidity during the 5 yrs preceding the start of this study;
2) data on age, sex and socioeconomic status; and 3) 
a family history (parents or siblings) of asthma. Data 
of chronic respiratory symptoms, smoking behaviour, 
airways obstruction, BHR and allergy were collected in 
the winter of 1989-1990.
The questionnaire was based on the standardized 
questionnaire on four respiratory symptoms (children’s 
version) of the British Medical Research Council (BMRC) 
and the American Thoracic Society (ATS) [16]. Its re­
producibility had been found to be satisfactory [17]. All 
subjects completed the questionnaire by themselves.
The four questions on "chronic respiratory symptoms" 
are listed in table 1. A question on smoking habits was 
added by us. A subject was considered "symptomatic” 
in the case of an affirmative answer to at least one of 
the four questions on chronic symptoms.
Spirometry was carried out with a portable flow- 
volume meter (Microspiro HI-298, Chest Corp., Tokyo, 
Japan) [18]. Each subject had to perform three satisfac­
tory forced vital capacity (FVC) manoeuvres (values 
within 10% of each other). Data were taken from the high­
est sum of FVC and the FEV l . Subjects who had a FEV1 
<(FEVl pred -2 sd ) [19, 20] were considered to have 
airways obstruction.
Table 1. -  Responses of the study group (n=551) to 
questions on chronic respiratory symptoms and smok- 
ing behaviour __________________________________
Question Positive
response
_________________________________________________________________________________________________________________________________________________________ %
1. Chronic cough: did you usually - at least 5 5 
days a week - cough (e.g. when getting up,
or during the day, or at night) during a period 
of at least three consecutive months?
2. Chronic cough with phlegm: have you 7 
coughed up phlegm, more than usually,
for at least three consecutive weeks in the 
last 12 months?
3. Wheezing: have you had wheezing in your 19 
chest in the last 12 months?
4. Tightness with wheezing: have you had 11 
attacks of tightness with wheezing in your
chest (attacks of asthma) in the last 12 months?
5. Smoking behaviour:
Do you smoke? 8
Have you ever smoked, but have stopped 5
smoking?
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The provocative concentration of histamine causing a 
20% decrease in FEVi (PC20) was assessed by means 
of the concise version of the European Respiratory Soc­
iety standardized tidal breathing procedure [20]. The 
combination of nebulizer and flow meter was calibra­
ted by a weighing method, to give an output of 0.13 
mL-mhr1. The tests were taken by field workers trained 
and supervised by the university lung function labora­
tory. International recommendations were followed ex­
actly: the starting concentration was adapted according 
the FEVi, the FEVi/inspiratory vital capacity (VC) ratio, 
and the use of inhaled medication. Following a 2 min 
inhalation of saline, histamine concentrations of 0.03-
16 mg^mL' 1 were inhaled. At 30 and 90 s after each 
inhalation, the forced expiratory manoeuvres were per­
formed to measure the response. The lowest FEVi value 
from an adequate maximum expiratory flow-volume 
(MEFV) curve was used for further evaluation. If the 
change in FEVi was less than 5%, the next dose was 
omitted. A 5 min interval was taken between the start 
of inhaling two successive doses. Bronchodilators and 
antihistamines, when used, were withheld at least 8 and 
48 h, respectively, before the test. When a subject re­
ported a respiratory tract infection with fever in the last
6 weeks, the test was postponed until at least 6 weeks 
after the end of the infection. Results were expressed as 
the PC20 histamine. Subjects with a PC20 <8.0 mg-mL*1 
were considered to have BHR [20].
Allergic response to inhalant allergens was assessed 
by the Phadiatop-test (Kabi Pharmacia Diagnostics AB, 
Uppsala, Sweden) [21]. The test was considered posi­
tive when the ratio (subject’s serum/reference serum) 
was higher than 1.
Analysis
An analysis was performed to assess whether the par­
ticipants in this study formed a representative sample 
of the original birth cohorts. For that purpose, they were 
compared with those of the original birth cohorts who 
did not belong to the study group. The comparison was 
made for sociodemographic features and for respira­
tory morbidity recorded in the first 5 yrs of life. The 
children who had left the practices before the age of 5 
yrs (from whom not all the necessary data were avail­
able) were, therefore, ignored in this respect.
The study group was also compared with those who 
were invited for the study (n=926) but refused to par­
ticipate ("nonrespondents", n=375) regarding the respi­
ratory morbidity during the 5 yrs preceding the study, 
to assess the representativeness of the study group.
BHR was subdivided into symptomatic and asymp­
tomatic BHR, according to the reporting of chronic res­
piratory symptoms. Respiratory illness episodes in early 
childhood were separately related to BHR, both symp­
tomatic and asymptomatic. They were handled as dicho- 
tomous variables in a historical cohort analysis. For 
each relationship the relative risk (RR) and its 95% con­
fidence intervals (95% CIs) were assessed. The asymp­
tomatic hyperresponsive subjects and the symptomatic 
hyperresponders were compared with the nonhyperre- 
sponsive group and with each other, with respect to the 
following personal and clinical characteristics connec­
ted to asthma: sociodemographic features; recent respi­
ratory morbidity; family history (parents or siblings) of 
asthma; smoking habits (ever or never); allergy to inha­
lant allergens; and airways obstruction. All of the char­
acteristics were handled as dichotomous variables in a 
cross-sectional analysis. For each comparison the odds 
ratio (OR) and its 95% CIs were assessed.
A multiple logistic regression analysis was carried 
out, to ensure that each factor which was found to be re­
lated to BHR remained independently related to it after 
controlling for the other factors (excluding recent res­
piratory illnesses).
The analyses were repeated using more restrictive cri­
teria for BHR [22], namely BHR in case of PC20 <4.0 
and in case of <2.0 mg-mL-1, since the choice of the 
cut-off point is arbitrary [23, 24]. The value PC20 is 
reported to be dependent upon baseline airway patency 
[25]. In order to assess to what extent this was the case 
in the population of the present study, a Spearman’s rank 
correlation coefficient was calculated between baseline 
FEVi %pred and log (PC20 +1) for those who achie­
ved a 20% fall in FEVi during bronchial challenge.
A Chi-squared test was used to determine the signif­
icance of the associations and the differences. All analy­
ses were performed using the Statistical Analysis System 
(SAS) package (SAS Institute Inc., Cary, NC, USA). A 
p-value of <0.05 was considered significant.
The study was approved by the Ethics Committee of 
the Faculty of Medical Sciences of the University of 
Nijmegen.
Results
The study group included significantly fewer male sub­
jects and fewer subjects of the highest social class and 
presented more episodes of respiratory morbidity in early 
childhood, compared to those of the original birth cohort 
not participating in the study (table 2).
In the study group, more subjects had episodes of 
acute bronchitis and hay fever in the 5 years preceding 
the study, as compared to nonrespondents (table 3).
The distribution of PC20 values in the study group is 
shown in figure 2. BHR could be demonstrated in 232 
subjects (42% of the study group). One or more chro­
nic respiratory symptoms were present in 143 subjects 
(26%). Of those with BHR, 70% did not report any 
chronic respiratory symptom (fig. 1).
Table 4 shows the relationship between respiratory 
illnesses in the first 5 yrs of life and BHR when aged 
10-23 yrs. Only acute bronchitis in early childhood was 
related to BHR in adolescence and young adulthood 
(RR=1.3; p=0.02). However, this association was only 
present for those with symptomatic BHR.
The results of the comparisons between subject groups 
with asymptomatic BHR, symptomatic BHR, and non- 
BHR, with respect to a family history of asthma, smok­
ing habits, presence of allergy, of airways obstruction 
and of recent respiratory illnesses are shown in table 5. 
The comparison between subjects with asymptomatic 
BHR and non-BHR did not show significant differ­
ences.
In the symptomatic BHR group, more subjects had 
an allergy, airways obstruction or recent respiratory 
morbidity (namely, asthma, acute bronchitis and hay
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Table 2. -  Study group (n=551) compared to those lost 
to follow-up* (n=214) and nonrespondents (n=375)
4 0 -
Study group
%
Practice leavers and 
nonrespondents
% p-value
Sociodemographic features
Age
<16 yrs 56 53 0.49
>16 yrs 44 47
Sex
Male 50 57 0.03
Female 50 43
Social class
Upper 6 10 0.005
Middle 45 38
Lower 49 52
Early childhood morbidity 0-4 yrs*
Asthma
0 96 97 0.30
>1 4 3
Acute bronchitis
0 64 70 0.03
1 20 19
>2 16 11
Pneumonia
0 91 93 0.27
>1 9 7
Hay fever
0 97 99 0.02
>1 3 1
Otitis media
0 42 48 0.04
1 25 26
>2 33 26
Tonsillitis
0 46 55 0.007
1 26 21
>2 28 24
Laryngitis
0 91 94 0.06
>1 9 6
Common cold
0-1 23 29 0,05
2-3 25 28
4-5 21 18
>6 31 25
*: children who left practices at age <5 yrs (n=301) were exclud­
ed, since not all morbidity data of the first 5 years of life were 
available; #: number of episodes of respiratory disease.
Table 3. -  Comparison between study group (n=551) 
and the nonrespondents (n=375)
Recent respiratory 
illnesses*
(1985-1989)
Study
group
%
Nonrespondents
% p-value
Asthma 4 3 0,47
Acute bronchitis 7 3 0.03
Pneumonia 2 2 0.78
Hay fever 11 7 0.04
Common cold 34 32 0,21
Laryngitis 1 1 0.78
Tonsillitis 11 10 0,64
Otitis media 11 10 0,70
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Fig, 2. -  Frequency histogram o f the values of PC20 histamine found 
in the study group. PC20 was measured using the shortened version 
of the tidal breathing method, according to the European Respiratory 
Society (ERS) standardized lung function testing, Forty two percent 
of this population has a PC20 <8 mg*mL-1. PC20: provocative con­
centration of histamine producing a 20% decrease in forced expira­
tory volume in one second.
at least one episode.
fever), than in the nonhyperresponsive group and in the 
asymptomatic hyperresponsive group. No differences 
were found for sex, age, social class, family history of 
asthma and smoking behaviour between symptomatic 
BHR, asymptomatic BHR and non-BHR. Multiple logi­
stic regression analysis showed that acute bronchitis in 
early childhood, allergy and airways obstruction were 
independently related to BHR.
When PC20 values of 4.0 and 2,0 mg-mL-1 histamine 
were chosen as cut-off points for BHR, the overall preva­
lence of BHR was 24 and 14%, respectively; with 60 
and 53%, respectively, being asymptomatic (14 and 7%, 
respectively of the whole population). These more restric­
tive criteria did not essentially change the correlation 
between BHR and early childhood morbidity, nor bet­
ween BHR and the other factors examined; furthermore, 
the differences between asymptomatic and symptomatic 
BHR with respect to the associations with these factors 
remained the same.
For those who achieved a 20% fall in FE V l during 
bronchial challenge (PC20 <16 mg-mL1 histamine; n=369, 
67% of the study group) no correlation was found between 
baseline FEVl % pred and log (PC20 +1) (Spearman's 
rank correlation coefficient = 0.04).
Discussion
The prevalence of BHR, defined by a PC20 <8 mg-mL'1, 
in this sample of adolescents and young adults was 42%, 
of which 70% were asymptomatic. This study indicat­
ed a relationship between BHR in adolescence and 
young adulthood and LRTI in early childhood for sub­
jects with symptomatic BHR, but not for those with 
asymptomatic BHR. No differences were found with 
respect to personal and clinical characteristics related to 
asthma between asymptomatic subjects with BHR and 
those without BHR. However, symptomatic BHR dif­
fered strongly from asymptomatic BHR in this regard.
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Table 4. -  Respiratory illnesses in the first 5 yrs of life (n=551) in relation to BHR at 10-23 yrs of age
Respiratory All hyperresponsive Symptomatic# Asymptomatic
illnesses (n=232; 42%) hyperresponsive hyperresponsive
at age 0-4  yrs vs nonhyperresponsive (n=70; 13%) vs (n=162; 29%) vs
subjects nonhyperresponsive nonhyperresponsive
(n=319; 58%) subjects subjects
n* RR 95% Cl RR 95% Cl RR 95% Cl
Asthma 22 1.0 0.6- 1.6 1.6 0.7-3.4 0.7 0.3-1 .6
Acute bronchitis 200 1.3* 1.0- 1.5 2.0** 1.3-3.0 1.1 0.9-1.5
Pneumonia 46 LO 0.7-1.4 1.3 0.7-2,5 0.8 0.5-1.4
Hay fever 15 0.6 0.3-1.5 0.9 0.2-3.1 0.5 0 .1- 1.6
Common cold 277 1,0 0 .8- 1.2 1.0 0.6- 1.5 0.9 0.7-1 .1
(>4 episodes)
Laryngitis
Tonsillitis
48 1.3 1.0- 1.8 1.7 0.9-3.1 1.3 0.9-1.9
301 1.0 0.9-1.3 0.8 0.5-1.2 1.2 0.9-1.5
Otitis media 319 0.9 0.8- 1.1 1.2 0.8- 1.9 0.9 0.7-1 .1
Relative risk (RR) and 95% confidence interval (95% Cl) for all subjects with bronchial hyperresponsiveness (BHR), defined a 
PC20 <8.0 mg-mL-1, for those with symptomatic BHR and for those with asymptomatic BHR, compared with nonhyperrespon 
sive subjects. in case of an affirmative answer to at least one of the questions on chronic respiratory symptoms; *: those wh< 
presented at least one episode, unless otherwise indicated, PC20: provocative concentration of histamine causing a 20% decreas 
in forced expiratory volume in one second. *: p<0.05; **: pcO.Ol.
Table 5. -  Asymptomatic bronchial hyperresponsiveness (BHR) and symptomatic# BHR compared with non-BHF 
and with each other with respect to subject and clinical characteristics
Personal and 
clinical
characteristics
(n=551)
n+ %
Asymptomatic 
hyperresponsive 
(n=d62) vs 
nonhyperresponsive 
subjects (n=319)
OR 95% Cl
Symptomatic 
hyperresponsive 
(n=70) vs
nonhyperresponsive
subjects (n=319) 
OR 95% Cl
Symptomatic 
hyperresponsive 
(n=70) vs asympto­
matic hyperresponsivi 
subjects (162)
OR 95% Cl
Family history of 
asthma
109 20 1.2 0.7-1.9 1.0 0.5-1.9 0.8 0.4-1.7
Smoking 130 24 0 .6* 0.3-0.9 1.0 0.6—1.9 1.9 1.0-3.6
Allergy* 163 33 1.3 0 .8- 2.0 3.4*** 2.0- 6.0 2.6** 1.5-4.8
Airways obstruction 
Recent respiratory
93 17 
illnessest (1985-1989)
L5 0.9-2 .6 3.6*** 2 .0- 6.6 2.4** 1.3-4.5
Asthma 21 4 0.8 0.2-3.3 8.3*** 3.1-22.3 9 9*** 2.7-36.7
Acute bronchitis 36 7 1,0 0.5-2.4 3.0** 1.3-6.9 2^9* 1.2-7.5
Pneumonia 12 2 0.8 0.2-3.3 1.3 0.3-6.5 1,6 0.3-9.7
Hay fever 60 11 0.8 0,4—1.6 3.8*** 2.0-7.3 4.8*** 2 .2- 10.6
Common cold 219 40 1.1 0 .8- 1.6 1.6 1.0-2.7 1.5 0 .8- 2.6
Laryngitis 5 1 - _$ 7.2* 1.2-44.0 - _$
Tonsillitis 58 11 0.6 0.3-1.2 1.0 0.4-2,2 1.6 0.6-4.2
Otitis media 57 11 0.8 0.4-1.5 1.1 0.5-2.4 1.4 0.6-3.5
BHR was defined as a PC20 <8 mg-mLA *: missing 59 subjects. Odds Ratio (OR) and 95% confidence interval (95% Cl) foi 
all subjects (n=551) with asymptomatic BHR, compared with nonhyperresponsive subjects, and for those with symptomatic BHF 
compared with nonhyperresponsive subjects and with asymptomatic hyperresponders, respectively. #: in case of an affirmative 
answer to at least one of the questions on chronic respiratory symptoms; +: numbers and percentages refer to the whole popula­
tion (n=551); at least one episode;$: none of those with asymptomatic BHR presented laryngitis in 1985-1989. PC20: provoca­
tive concentration of histamine causing a 20% decrease in forced expiratory volume in one second. *: p<0.05; **: p<0 .01; ***
pcO.OOl.
These findings are not consistent with the hypothesis 
that asymptomatic BHR constitutes a link between early 
childhood LRTI and asthma in later life.
The present survey produced a high rate of BHR, 
higher than found in several other studies but not un­
common in comparable populations. BHR prevalence 
in random population studies ranges 4-64% [3-5, 23, 
26]. These studies differ in the following factors: the 
prevalence of asthma and other atopic diseases; the age 
of the groups; the method used to measure bronchial 
responsiveness; and the threshold value for hyperre­
sponsiveness. In the present group of subjects, select­
ed from the records of general practices only on the 
basis of date of birth, the prevalence of asthma and hay
fever, diagnosed during the 5 yrs preceding this study, 
was 4% and 11%, respectively. However, underdiag­
nosis in general practice has also been reported in many 
studies and has been shown in this study group [21], 
The incidence of BHR in the present study lies be­
tween that found by C ockcroft et a l  [23] (64% of a 
group of 300 students aged 20-29  yrs, with a PC20 <8.0 
mg-mL"1), and Backer et al. [28] (16% of 527 subjects 
aged 7—16 yrs, with a PC20 <8.0 mg-mL-1)* Trigg et a l  
[29] studied 366 subjects, recruited from four general 
practices in the UK, and performed standardized metha- 
choline challenges. In the UK, persons are included in 
the registers of general practitioners on the same basis 
as in the Netherlands. They found a prevalence of BHR
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(defined by PC20 methacholine <2 mg-mL’1) of 23%. 
However, if they had applied the criterion of PC20 <8 
mg-mL"1 to their data, they would have found a preva­
lence of 38% in a population recruited in a way compa­
rable to ours. T rigg et al. [29] also quoted an Australian 
study reporting a 35% prevalence of BHR in a popula­
tion of college students. Absence of symptoms has been 
found by others in a substantial proportion of hyper- 
responsive children (41%; 7% of the total population)
[5], and adults (59%; 14% of the total population) [4]. 
Consequently, we consider that the prevalence of BHR 
of 42% in our study group is high, but not unprece­
dented.
The questionnaire may have been biased in its Dutch 
translation towards the "Dutch hypothesis", by focus­
ing not only on asthma but also on COPD, especially 
with the questions on persistent chronic cough. This 
may have caused underreporting of asthma symptoms. 
However, chronic cough can be the sole clinical mani­
festation of asthma, and COPD is rare in the age cate­
gory of our study group.
The sample of the present study was selected by date 
of birth only from registers of general practitioners. The 
subjects were adolescents and young adults, who vol­
unteered to take part in the screening. Self-selection 
may have been a factor of influence, with "healthier" 
subjects less likely to participate. The comparison be­
tween our study group and the original birth cohorts did 
not reveal important differences. Therefore, it is unlike­
ly that selection bias was an important cause of the high 
prevalence of BHR found in this study. It was proba­
bly not the result of recent respiratory infections either, 
since in that case the histamine challenge test was post­
poned for 6 weeks. Most tests were performed in Dec­
ember and January, thus avoiding the influence of the 
grass pollen season.
A standardized method for testing BHR was used [20], 
and the recommendations issued for its use were fol­
lowed exactly. Nebulizers and spirometers were cali­
brated regularly. Data from inadequately performed forced 
expiratory manoeuvres were excluded from the analy­
sis. The field testing was performed by trained personnel, 
supervised by the university lung function laboratory. 
As a consequence, we consider it unlikely that the high 
prevalence of BHR is due to poor methodology.
Early childhood LRTI and subsequent symptomatic or 
asymptomatic BHR
Acute bronchitis in early childhood was related to BHR 
at 10-23 yrs of age, a finding consistent with other stud­
ies relating early childhood respiratory illness and sub­
sequent BHR [30, 31]. It still has to be established 
whether this relationship results from early childhood 
LRTI, predisposing children to later BHR by triggering 
causal mechanisms, or whether the childhood LRTI are 
an early expression of BHR. It should be realized that, 
in this study, the classification "acute bronchitis" includes 
bronchiolitis, which is related to subsequent pulmonary 
function abnormalities and asthma [32]. However, this 
cannot be explored in the present study, due to lack of 
specific information. "Acute bronchitis" may be liable 
to misclassification: asthma-like symptoms, registered
as acute bronchitis, could have been a first manifesta­
tion of asthma.
BHR should not be regarded as a specific entity in 
itself. It can merely result from airway narrowing. In 
the present study, no correlation was found between 
PC20 and baseline FEVl, which is in accordance with 
T wentyman et al. [33], In our view, submucosal chan­
ges are more important determinants for BHR, as re­
flected in the hypothesis raised at the start of this study. 
However, our study did not support this hypothesis, as 
did a recent study in adolescents [10]. The latter study 
used a more restrictive definition of BHR, but applica­
tion of more restrictive definitions of BHR in our ana­
lysis, with lower histamine thresholds, did not change 
the results.
Characteristics of symptomatic and asymptomatic BHR
In the present study group, the considerable differ­
ences between asymptomatic and symptomatic BHR, and 
the similarities of the characteristics of asymptomatic 
BHR and non-BHR subjects, suggest that asymptomatic 
BHR is an entity, completely independent of asthma. 
Therefore, this does not support the hypothesis that asymp­
tomatic BHR precedes the development of asthma [9, 
10].
The present analysis does not allow firm conclusions 
regarding asymptomatic BHR as a risk factor for future 
asthma. To that end, further longitudinal studies are need­
ed, with a close follow-up of asymptomatic BHR.
It has been suggested that hyperresponsive subjects 
may be asymptomatic because of poor recognition of 
symptoms [8]. However, in the present study, sympto­
matic and asymptomatic hyperresponsive subjects also 
differed in a number of characteristics that are tiistinct 
from symptom perception. Therefore, perception does 
not seem to be a determining factor in explaining the 
difference between the two forms of BHR.
BHR in this and other surveys was assessed at one 
moment in time. The reproducibility of the histamine 
challenge test is good [20], but bronchial responsive­
ness can vary considerably with time due to external 
factors [6, 34], In general, the group with asymptomatic 
BHR had lower levels of BHR than the group with 
symptomatic BHR, and this mild BHR may disappear
[6]. However, this does not seem an important factor, 
as the application of more restrictive definitions of BHR 
did not essentially change the results.
In summary, this study does not support the hypo­
thesis that asymptomatic bronchial hyperresponsive­
ness constitutes a link between early childhood lower 
respiratory illnesses and asthma in later life, nor for 
asymptomatic bronchial hyperresponsiveness to be a 
risk for subsequent asthma.
Acknowledgements: The authors are indebted to the 
participants in this study and their parents for their co­
operation, and the general practitioners and the practice 
assistants of the CMR practices for their assistance. They 
gratefully acknowledge the help of L.M. Bierman, H. 
Janssen, L. Klerks, P. Pennings, C.B, Poelen and T.J.M. 
Teunissen in measuring Lhe subject's lung function and 
bronchial responsiveness. They are also very grateful to 
W. Tiersma for his computer assistance and to J. Lummen 
for his linguistic comments.
50 B.G.M. KOLNAAR HT AL.
References 18.
1. Hall WJ, Hall CB, Speers DM. Respiratory syncytial 
virus infection in adults: clinical, virologic and serial pul­
monary function studies. Ann Intern Med 1978; 88: 19. 
203-205.
2. Lemanske RF Jr, Dick EC, Swenson CA, e ta l  Rhinovirus
upper respiratory infection increases airway hyperreac- 20. 
tivity and late asthmatic responses. J Clin Invest 1989;
83: 1-10.
3. Salome CM, Peat JK, Britton WJ, Woolcock AJ. Bronchial 2 1. 
hyperresponsiveness in two populations of Australian 
schoolchildren. 1. Relation to respiratory symptoms and 
diagnosed asthma. Clin Allergy 1987; 17: 271-281.
4. Rijcken B, Schouten JP, Weiss ST, Speizer FE, Van der 22. 
Lende R. The relationship of nonspecific bronchial res­
ponsiveness to respiratory symptoms in a random pop­
ulation sample. Am Rev Respir Dis 1987; 136: 62-68.
5. Pattemore PK, Asher MI, Harrison AC, Mitchell EA, 23. 
Rea HH, Stewart AW. The interrelationship among 
bronchial hyperresponsiveness, the diagnosis of asthma,
and asthma symptoms. Am Rev Respir Dis 1990; 142:
549-554. 24.
6. Peat JK, Salome CM, Sedgwick CS, Kerrebijn J, Woolcock
AJ. A prospective study of bronchial hyperresponsive- 25. 
ness and respiratory symptoms in a population of Australian 
schoolchildren. Clin Exp Allergy 1989; 19: 299-306.
7. de Gooijer A, Brand PLP, Gerritsen J, Koeter GH, Postma 
DS, Knol K. Changes in respiratory symptoms and air­
way hyperresponsiveness after 27 years in a population- 26. 
based sample of school children. Eur Respir J 1993; 6:
848-854.
8. Brand PLP, Rijcken B, Schouten JP, Koeter GH, Weiss 
ST, Postma DS, Perception of airway obstruction in a 
random population sample: relation to airway hyperre- 27. 
sponsiveness in the absence of respiratory symptoms.
Am Rev Respir Dis 1992; 146: 396-401.
9. Hopp RJ, Townley RG, Biven RE, Bewtra AK, Nair 
NM. The presence of airway reactivity before the dev­
elopment of asthma. Am Rev Respir Dis 1990; 141: 2-8, 28.
10. Zhong NS, Chen RC, Ou Yang M, Wu ZY, Zheng JP,
Li YF. Is asymptomatic' bronchial hyperresponsiveness 
an indication of potential asthma? A two year follow-
up of young students with bronchial hyperresponsive- 29. 
ness. Chest 1992; 102: 1104-1109.
11. Sherman CB, Tosteson TD, Tager IB, Speizer FE,
Weiss ST. Early childhood predictors of asthma. Am J 
Epidemiol 1990; 132: 83-95.
12. Kolnaar BGM, Van Lier A, Van den Bosch WJHM, 30. 
et al. Asthma in adolescents and young adults: rela­
tionship with early childhood respiratory morbidity. Br
J Gen Pract 1994; 44: 73-78.
13. van Weel C. Validating long-term morbidity recording.
J  Epidemiol Commun Health 1995; 49 (Suppl,): 29-32. 31.
14. van Weel C. Chronic diseases in general practice: long­
term dimension. Eur J Gen Pract 1996; 2: 17-21.
15. van Weel C, van den Bosch WJHM, van den Hoogen 32. 
HJM, Smits AJA. Development of respiratory illness in 
childhood: a longitudinal study in general practice. J  R
Coll Gen Pract 1987; 37: 404-^08. 33.
16. Ferris BG. Epidemiology standardization project. II. 
Recommended respiratory disease questionnaires for
use with adults and children in epidemiologic research. 34. 
Am Rev Respir Dis 1978; 118 (Suppl.): 7-53.
17. Brunekreef B, Groot B, Rijcken B, Hoek G, Steenbekkers 
A, De Boer A. Reproducibility of childhood respira­
tory symptom questions. Eur Respir J 1992; 5: 930-955.
Dompeling E, Van Schayck CP, Folgering H, Van den 
Hoogen HJM, van Weel C. Accuracy, precision and lin­
earity of the portable flow-volume meter, Microspiro 
HI-298. Eur Respir J 1991; 4: 612-615.
Zapletal A, Samanek M, Paul T. Lung function in chil­
dren and adolescents. In: Herzog H, ed. Methods, Refer­
ence Values. Basel, S. Karger AG, 1987; pp. 1-220. 
Working party of the European Respiratory Society. 
Standardized lung function testing. Eur Respir J  1993;
6 (Suppl. 16): 5-100.
Matricardi PM, Nisini R, Pizzolo JG, Amelio R. The 
use of Phadiatop in mass-screening programmes of inhalant 
allergies: advantages and limitations. Clin Exp Allergy
1991; 20: 151-155.
Backer V, Groth S, Dirksen A, et al. Sensitivity and 
specificity of the histamine challenge test for the diag­
nosis of asthma in an unselected sample of children and 
adolescents. Eur Respir J  1991; 4: 1093-1100. 
Cockcroft DW, Berscheid BA, Murdock KY. Unimodal 
distribution of bronchial responsiveness to inhaled his­
tamine in a random human population. Chest 1983; 83: 
751-754.
Tattersfield AE, Higgins BG. Bronchial reactivity in the 
community. Eur Respir J  1988; 1: 476-491.
Ryan G, Latimer KM, Dolovich J, Hargreave FE. Bron­
chial responsiveness to histamine: relation to diurnal 
variation in peak flow rate, improvement after bron- 
chodilator usage, and airway calibre. Thorax 1982; 37:
423-429,
Zhong NS, Chen RC, Ou-yang M, Wu JY, Fu WX, Shi 
LJ. Bronchial hyperresponsiveness in young students of 
southern China: relation to respiratory symptoms, diag­
nosed asthma and risk factors. Thorax 1990; 45: 860- 
865.
Kolnaar BGM, Beissel E, Van den Bosch WJHM, Folgering 
H, Van den Hoogen HJM, Van Weel C. Asthma in ado­
lescents and young adults: screening outcome versus 
diagnosis in general practice. Family Practice 1994; 11:
133-140.
Backer V, Dirksen A, Bach-Mortensen N, et al. The 
distribution of bronchial responsiveness to histamine 
and exercise in 527 children and adolescents. J Allergy 
Clin Immunol 1991; 88: 68-76.
Trigg CJ, Bennett JB, Tooley M, Sibbald B, D'Souza 
MF, Davies RJ. A general practice based survey of 
bronchial hyperresponsiveness and its relation to symp­
toms, sex, age, atopy and smoking. Thorax 1990; 45: 
866-872.
Weiss ST, Tager IB, Munoz A, Speizer FE. The rela­
tionship of respiratory infections in early childhood to 
the occurrence of increased levels of bronchial respon­
siveness and atopy. Am Rev Respir Dis 1985; 131: 
573-578.
Peat JK, Salome CM, Woolcock AJ. Factors associa­
ted with bronchial hyperresponsiveness in Australian 
adults and children, Eur Respir J 1992; 5: 921-929. 
Pullan CR, Hey EN. Wheezing, asthma and pulmonary 
dysfunction 10 years after infection with respiratory 
syncytial virus in infancy. BrMedJ  1982; 284: 1665-1669. 
Twentyman OP, Hood SV, Holgate ST. Does baseline 
airway calibre affect measurement of airway respon­
siveness to histamine? JAppl Physiol 1993; 74:3034-3039. 
Britton JR, Burney PGJ, Chinn S, Papacosta AO, 
Tattersfield AE. The relation between change in airway 
reactivity and change in respiratory symptoms and med­
ication in a community study. Am Rev Respir Dis 1988; 
138: 530-534.
